Confo Therapeutics Expands Patent Estate for ConfoBody-based GPCR Screening Platform

Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that it has extended its patent estate with four key US and EU patents granted

Related Keywords

Belgium ,Cedric Ververken ,Valeria Fisher ,Kostenloser Wertpapierhandel ,Trophic Communications ,Regeneron Inc ,Confo Therapeutics ,Jan Steyaert ,Chief Executive Officer ,Confo Therapeutic ,Vrije Universiteit Brussel ,Confo ,Herapeutics ,Xpands ,Patent ,Estate ,Onfobody ,Ased ,Pcr ,Screening ,Platform ,